戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tands, 1.9 for standing balance, and 1.7 for grip strength.
2 -m walk, chair stands, standing balance) and grip strength.
3 in, hair, and eye color, blood pressure, and grip strength.
4 .52, p = .001) and left (r = 0.50, p = .002) grip strength.
5 , were taller, more muscular, and had higher grip strength.
6 d neurological recovery weekly by upper-limb grip strength.
7 ysial collagen III deposition, and hind limb grip strength.
8 l nucleation, fibrosis and declined forelimb grip strength.
9 ociation was attenuated after adjustment for grip strength.
10 uch as elevated pain sensitivity and reduced grip strength.
11  dismutase in spinal motor neurons preserved grip strength.
12         These findings were not explained by grip strength.
13 was generally associated only with increased grip strength.
14 ysmetria and dysdiadochokinesia but not with grip strength.
15 ation, speech and swallowing assessments and grip strength.
16 g telomere length, the epigenetic clock, and grip strength.
17 that was 30 percent of the maximal voluntary grip strength.
18 dent OA at different hand joints and maximal grip strength.
19 trically measured flexed arm muscle mass and grip strength.
20 , quality of life, activity levels, and hand grip strength.
21 ficit partially attributed to a reduction in grip strength.
22 taneous fat and muscle loss, edema, and hand grip strength.
23 score, the Clinical Frailty Scale (CFS), and grip strength.
24 nt in three out of seven pinches and overall grip strength.
25 tion of fibrosis and restoration of forelimb grip strength.
26  were more robust for walking speed than for grip strength.
27 uding robust hind limb elements modified for grip strength.
28 , mechanical hypersensitivity, and decreased grip strength.
29 paired motor control, exercise capacity, and grip strength.
30  5.3 (women) cm/s difference), six years for grip strength (0.10, 0.01 to 0.20; 0.9 (men) and 0.6 (wo
31 thresholds were 0.86 (95% CI, 0.80-0.92) for grip strength, 0.94 (95% CI, 0.88-1.01) for timed walk,
32 er 3 months on the waiting list: -0.38 kg in grip strength, -0.05 meters/second in gait, 0.03 seconds
33 nction findings in his right/left hand were: grip strength: 10/13 kg; key pinch: 3/3 kg; Kapandji sco
34  weight-supported hanging (43% increase) and grip strength (25% increase), were obtained after hypoth
35 he WMFT (-1.39 kg, -2.74 to -0.04), for WMFT grip strength (-4.39 kg, -6.91 to -1.86), for amount of
36 0.26 kg, P < 0.001; 11 studies, n = 308) and grip strength (5.3%, P < 0.050; 4 studies, n = 156), whi
37 ters, comorbidities, Clinical Frailty Scale, grip strength, 5-meter walk test, and pulmonary function
38 ed swollen and tender joint count and score, grip strength, 50-foot walking time, duration of morning
39 e we examine the morphological correlates of grip strength, a defensive combat trait involved in mate
40 ivation of the Col12a1 gene showed decreased grip strength, a delay in fiber-type transition and a de
41 iation study in 340,319 individuals for hand grip strength, a proxy measure of muscle strength.
42             We also collected lung capacity, grip strength, a series of balance tests, and a timed wa
43                                              Grip strength, a surrogate for quantifying strength, cor
44 5% confidence interval: 1.04, 6.84), and low grip strength (adjusted odds ratio = 3.29, 95% confidenc
45 led paw reaching after correct repair and in grip strength after crossover repair.
46 ge, sex, race, cognition, comorbidities, and grip strength, AMD subjects showed an increased likeliho
47 ons of radiographic variables with pinch and grip strength among individuals with radiographic hand O
48 sed risk (95% CI, 1%-23%) of developing weak grip strength and a 14% decreased risk (95% CI, 8%-20%)
49 ulted in significant improvement in hindlimb grip strength and a 30% decrease in inflammation in the
50                                         Hand grip strength and ADL tended to recover to baseline earl
51 idisciplinary expert team measured patients' grip strength and assessed their predicted mobilization
52                                         High grip strength and avoidance of overweight, hyperglycemia
53 ligible patients had low performance on hand grip strength and chair rise tests, tested with the proc
54 width), measures of muscle health (e.g. hand grip strength and computed tomography scan results), end
55  decline in normalized forelimb and hindlimb grip strength and declines in in vitro EDL force after r
56  observed for cardiovascular mortality.Lower grip strength and excess adiposity are both independent
57 idant intake was associated with increase in grip strength and faster gait speed in this cohort of ad
58       A chronic high-fat diet led to reduced grip strength and force profile when normalized to body
59 d statin-associated muscle damage diminished grip strength and force profile, without affecting cumul
60 d osteoarthritis and to assess its impact on grip strength and functional activities.
61 th performance; those in the lowest fifth of grip strength and highest fifth of BMI having particular
62     No association was found between maximal grip strength and incident OA in the DIP joints of men o
63 ease onset, weight loss, decline in hindlimb grip strength and increased animal survival.
64 ured using dual energy x-ray absorptiometry; grip strength and information on lifestyle indicators, i
65 was significantly associated with both lower grip strength and lower pinch strength.
66                                              Grip strength and manual dexterity were not changed by r
67                                     In fact, grip strength and maximum isometric tetanic force are ev
68 ansplantation levels on all tests except for grip strength and motor dexterity.
69 ination reduced or prevented disease-related grip strength and object recognition deficits, mHTT accu
70                                              Grip strength and observed functional performance were e
71 from 5.0 to 2.9 mm; P = .02), but changes in grip strength and pain were not significant for control
72 function was assessed by measuring pinch and grip strength and peripheral vibration thresholds.
73 d higher risk of falling, whilst higher hand grip strength and physical activity were protective.
74 havioral (Digiscan) and functional outcomes (grip strength and Rotarod) were assessed prior to sacrif
75 that likely relate to self-selection such as grip strength and self-rated health.
76  function, assessed by skilled paw reaching, grip strength and sensory testing varied with accuracy o
77  to reduce the likelihood of developing weak grip strength and slow walking speed because purpose has
78 ssociated with lower risk of developing weak grip strength and slow walking speed over time.
79 ted with a decreased risk of developing weak grip strength and slow walking speed, although the findi
80 paired voluntary running capacity and muscle grip strength and that their gastrocnemius muscle contai
81 nsight into the mechanistic underpinnings of grip strength and the causal role of muscular strength i
82  pressure and attenuation of decline in both grip strength and time to death.
83 with a control group differed on functional (grip strength and walk time) and disease activity (total
84 rove locomotive function as well as forelimb gripping strength and coordination.
85 t physical performance battery; Zubrod; hand grip strength) and health-related quality of life (EuroQ
86  score, a 1.12-kg (95% CI: 0.83, 1.40) lower grip strength, and a 4.7-nm (95% CI: 3.5, 5.9) lower kne
87 ts in dystonic movements, motor performance, grip strength, and body weight that progressively worsen
88 nce score (sum of quartiles of walking pace, grip strength, and chair-stand speed; range, 0-9) were a
89 basic behavioral activities, impaired muscle grip strength, and defects in motor coordination.
90 ositive effects of exercise on walk time and grip strength, and demonstrated that fatigue and perceiv
91                                  Pain score, grip strength, and dexterity were measured before surger
92 hy Impairment Score of the Lower Limbs, hand grip strength, and evaluation of vegetative dysfunction,
93  strength, measured by hindlimb and forelimb grip strength, and heat nociception, measured by tail-fl
94 ors (ie, education, symptoms of depression), grip strength, and household and ambient pollution.
95        Treadmill exercise capacity, forelimb grip strength, and in vivo maximum tetanic force were al
96 played reduced spontaneous activity, loss of grip strength, and increased circulating levels of muscl
97 -min walking distance, fast gait speed, hand grip strength, and isometric leg extension strength).
98 ed significant improvements in paw reaching, grip strength, and ladder-rung walking in PIK3CD-treated
99 ce resulted in growth retardation, decreased grip strength, and loss of vocalization.
100 otor activity, contextual fear conditioning, grip strength, and motor learning, mainly in Tg but not
101 with transient increases in weight, forelimb grip strength, and myofiber size.
102 ipants were stratified by country, age, hand grip strength, and performance on the chair rise test, a
103 oss, exhaustion, low walking speed, low hand grip strength, and physical inactivity.
104 defects such as hind limb clenching, reduced grip strength, and reduced locomotor activity.
105 e walls of the vials, suggesting a defect in grip strength, and repeat the cycle of climbing and fall
106 low physical activity, exhaustion, decreased grip strength, and slow gait speed.
107 ere the number of tender and swollen joints, grip strength, and the erythrocyte sedimentation rate (E
108          FE65 family KO mice show attenuated grip strength, and the nuclei of DKO muscle cells freque
109 l class, as well as with the amount of pain, grip strength, and walking velocity.
110                        Men with high maximal grip strength are at increased risk for the development
111 g speed, chair rise speed, balance time, and grip strength assessed at ages 60 to 64 and 69 years.
112                  The risk of developing weak grip strength (assessed as a binary yes or no outcome) o
113                     After twenty-four hours, grip strength assessment revealed that Daf1(-/-) mice ex
114                    Additional measurement of grip strength at 4 weeks post-stroke and haemorrhagic st
115 otor functions, including breathing pattern, grip strength, balance beam and rotarod performance.
116                As endpoints, we measured the grip strength before and after an 8-week training protoc
117 ences (MDs) in change rates in gait speed or grip strength between anticholinergic TSDD and mSDD cate
118 treated mice exhibited improved body weight, grip strength, bone integrity, and percent survival at 2
119 ce, however, JQ1 had no effect on rotarod or grip strength but exacerbated weight loss and worsened p
120 icantly increased body weight, lean mass and grip strength by 60-80% over vehicle-treated mdx mice.
121 edly administered to effectively reduce hand-grip strength by approximately 50 % of control.
122 performed assessments such as gait speed and grip strength can be helpful to assess the fitness of an
123 on was measured in the physical [gait speed, grip strength, chair stand] and cognitive [digital symbo
124                                Consisting of grip strength, chair stands, and balance testing, the LF
125 er Frailty Index (LFI) score was calculated (grip strength, chair stands, and balance).
126        The final frailty index consisted of: grip strength, chair stands, and balance.
127                     The liver frailty index (grip strength, chair stands, balance) was measured at ev
128                                              Grip strength changes are a common metric used to assess
129 r adults in the home, body mass index (BMI), grip strength, cognitive ability, mood, or comorbid illn
130 ed reduced body and muscle mass and impaired grip strength compared with controls, which was accompan
131  demonstrated improved downward climbing and grip strength compared with those given vehicle, though
132 statistically significant (14 days) delay in grip strength decline but not in the onset of paralysis,
133                                  Significant grip strength declines observed in HRHF-Untreated and HR
134                                              Grip strength did not change in either group.
135                                              Grip strength did not differ between the groups.
136 9; 95% CI, 0.83-0.95), but associations with grip strength did not reach conventional levels of stati
137               The effects of birth weight on grip strength did not vary by childhood or current body
138 ty 25 years later increased as baseline hand grip strength, divided into tertiles, declined.
139 stimulation, and behavioural tests including grip strength, double simultaneous stimulation and joint
140 ound; African-American HRT users had greater grip strength during the study, whereas Caucasian HRT us
141  walk, 5 chair stands, standing balance, and grip strength, each scored from 0 to 4 (0, unable to per
142 but other measurements of strength (forelimb grip strength, ex vivo measurements of contractile funct
143 ds ratio = 2.43; 95% CI, 1.17-5.03) and poor grip strength, exhaustion, and slowed walking speed (haz
144                      Slow walking speed, low grip strength, exhaustion, low physical activity, and un
145                                 Both BMI and grip strength exhibited non-linear relations with perfor
146  across several movement qualities including grip strength, fine motor skills, and synergies and was
147 he 5 secondary criteria, and 3) substituting grip strength for HAQ scores.
148 /p+) and Ube3a(m-/p-) mice in rope climbing, grip strength, gait and a raised-beam task.
149 ater adverse changes in physical capability (grip strength, gait speed, and physical activity), senso
150 ailty was measured on a scale from 0 to 5 by grip strength, gait speed, exhaustion, shrinkage, and ph
151 s examined as a continuous variable based on grip strength, gait speed, serum albumin, and activities
152       Hand function measures: mean pinch and grip strength, GPT and AHFT completion times, smallest d
153 treatment decreased run time (RT) (-53%) and grip strength (GS) (-9%) compared to PBS.
154                                       Higher grip strength (GS) is associated with lower mortality ri
155               Men with greater leg power and grip strength had significantly reduced fall risk (for h
156 pollution, poor diet, low education, and low grip strength had stronger effects on cardiovascular dis
157 (HDL) cholesterol, forced expiratory volume, grip strength, HbA1c, longevity, obesity, self-rated hea
158 he last year were inversely related to adult grip strength, height, and walking speed in men and wome
159 mmonia, increase in lean body mass, improved grip strength, higher skeletal muscle mass and diameter,
160   Existing methods to statistically evaluate grip strength, however, have limitations in the power an
161 .21; 95% CI: 1.32, 3.71) and/or reduced hand grip strength (HR: 1.53; 95% CI: 10.07, 2.17) than in th
162 complex to calcium improves muscle force and grip strength immediately after administration of single
163    HW was superior compared to C in terms of grip strength improvement in three out of seven pinches
164  showed severe motor impairments and reduced grip strength in 4-month Crtap(-/-) mice - a phenotype t
165 d the relation between birth weight and hand grip strength in a prospective national birth cohort of
166 mouse or change gait, motor coordination, or grip strength in adult mice of both sexes.
167 s total intake, anthropometric measures, and grip strength in COPD.
168 brosis, and significantly improved hind limb grip strength in mdx mice.
169      Higher BMI was associated with stronger grip strength in men only.
170 -related somatic changes are correlated with grip strength in men, suggesting blood-derived whole gen
171       TCS acutely depresses hemodynamics and grip strength in mice at doses >/=12.5 mg/kg i.p., and a
172 proving intake, anthropometric measures, and grip strength in stable COPD.
173  baseline to endpoint were also recorded for grip strength in the dominant hand (treatment difference
174 mean differences between IADL, ADL, CFS, and grip strength in the haloperidol and placebo group were
175 on, in conjunction with a relatively tighter grip strength in the manual claws.
176 e yoga groups had significant improvement in grip strength (increased from 162 to 187 mm Hg; P = .009
177                                              Grip strength is a valuable preclinical assay to study m
178                                         Hand grip strength is a widely used proxy of muscular fitness
179                                              Grip strength is one aspect of psychomotor function that
180                     In contrast to Hyp mice, grip strength is preserved.
181 e rates are higher when the HAQ, rather than grip strength, is used to measure physical function.
182 nce intervals -16.786 to -4.482) decrease in grip strength (kg force) (P < 0.001) and -8.74 (95% conf
183                         Annualized change in grip strength (kg/y) and change in gait speed (m/s/y) ov
184 Truncal flexion and extension strength, hand grip strength, leg extension power, and quality of life
185             The most common pattern was poor grip strength, low physical activity, and slowed walk sp
186  cm for females), and dynapenia was based on grip strength (&lt;26 kg for males, <16 kg for female).
187 >/=30) in the lowest tertile of sex-specific grip strength (&lt;35.3 kg for men and <19.6 kg for women).
188 serum biochemistry, tissue weight, voluntary grip strength, maximal aerobic capacity (VO(2max)), body
189                                              Grip strength may be a valuable surrogate biomarker with
190 ic knee extension, plantar flexion, and hand grip strength measures.
191 articipants viewing TV >/= 6 hrs/d had lower grip strength (Men, B = -1.20 kg, 95% CI, -2.26, -0.14;
192 ast, internet use was associated with higher grip strength (Men, B = 2.43 kg, 95% CI, 1.74, 3.12; Wom
193 ded hindlimb and forelimb muscle strength by Grip Strength Meter and quantitative muscle fibrosis par
194 onal deficits were tested on the rotarod and grip-strength meter at 24, 48 and 72 h after pMCAO.
195  weights (HW) significantly improved overall grip strength more than a regular climbing training with
196 gnificant defects in motor skills, including grip strength, motor coordination, and gait and also rel
197 able-, or sarcopenic based on assessments of grip strength, muscle mass, and treadmill running time,
198 cin markedly improved their wellness scores, grip strength, neuropathology, and survival.
199         No significant changes in flexion or grip strength, no systemic allergic reactions, and no ne
200                          Only 7.8% of paired grip strength observations showed > or =20% improvement,
201 ain on an accelerating rotarod and increased grip strength observed in the pMCAO rats treated with PR
202      Galactosylceramide resulted in enhanced grip strength of forelimbs in male and female mice, bett
203 t 10 IU/day (but not at 1 IU/day), increased grip strength of the contralesional paretic forelimb and
204          Hand dominance was assessed by hand grip strength on a hand dynamometer.
205 ausal effect of higher genetically predicted grip strength on lower fracture risk.
206  9 months of age, whereas, losartan improved grip strength only at 2 months.
207 icting disability reduced the ORs related to grip strength only minimally.
208           No significant changes occurred in grip strength or dexterity from preoperative baseline to
209 were seen between the groups in knee or hand grip strength or in systemic endurance.
210 ere was no significant change of either hand grip strength or leg extension power.
211 o "work" and exert force (30%-70% of maximum grip strength) or "rest" (no effort) for rewards (2-10 c
212 , fixed-speed rotarod, accelerating rotarod, grip strength, or loss of righting reflex tests.
213 ght changes, lifespan, RotaRod performances, grip strength, overall activity and no significant effec
214 alysis identified shared brain correlates of grip strength, overall function, and well-being in a sam
215 ant impairments of joint range of motion and grip strength (P < .001).
216      Participants with CMT2A had the weakest grip strength (P < .05), while those with CMT2A and CMT4
217   The only ray significantly associated with grip strength (P < 0.05) was ray 1, and no individual ra
218 (P = .03) and B (P = .05), right-sided Jamar grip strength (P = .02), Rapid Pace Walk (P = .03), Brak
219 te perimenopause showed a 0.93-kg decline in grip strength (p = 0.07).
220 e postmenopausal showed a 1.04-kg decline in grip strength (p = 0.10) and a 0.57-kg decline in pinch
221 viduals and identify 16 loci associated with grip strength (P<5 x 10(-8)) in combined analyses.
222 02); and greater recovery of motor function (grip strength: p < 0.001).
223 of the erythrocyte sedimentation rate (ESR), grip strength, pain scores, tender joint counts, and anx
224                         For example, greater grip strength (per 6 kg) had an odds ratio (95% CI) of 0
225 -appearing brain was associated with: weaker grip strength, poorer lung function, slower walking spee
226 udy aimed to evaluate whether gait speed and grip strength predicted clinical outcomes among older ad
227 ll Pain Questionnaire Short Form, walk time, grip strength, predicted maximum oxygen uptake, and join
228 risk = 0.82, 95% CI: 0.73, 0.92; for highest grip strength quartile vs. lowest: relative risk = 0.76,
229 isease duration (r = 0.51 for each measure), grip strength (r = -0.49 for NDJ, and r = -0.51 for Shar
230                                         Hand grip strength recovered by 3 months after RARC (mean est
231 the risk of all-cause mortality increased as grip strength reduced within each BMI category.
232 tive relation between birth weight and adult grip strength remained after adjustment first for adult
233                                 Both BMI and grip strength remained independently related with perfor
234 cts with the disease had 10% reduced maximal grip strength, reported more difficulty writing, handlin
235   In multivariate models, the mean ESR, mean grip strength, rheumatoid factor positivity, and tender
236 monstrated significant motor deficits (e.g., grip strength, righting reflex and touch escape) in bf m
237  echocardiography, novel object recognition, grip strength, rotarod, glucose tolerance test (GTT) and
238       Frailty was measured by 4-m walk time, grip strength, self-reported weight loss, exhaustion, an
239 ent (beam walking, pole climbing, wire hang, grip strength), sensorimotor skills (rotarod), mechanica
240  3 weeks after stroke on locomotor activity, grip strength, sensory neglect, gait impairment, motor c
241  muscle measurements, such as hand pinch and grip strength, show the strongest correlation with disea
242                                         Hand grip strength showed earlier recovery in patients underg
243                                              Grip strength significantly decreased at 6 months.
244 ced vital capacity, resting heart rate, hand grip strength, sit and reach distance, and time standing
245 ur physical fitness tests (i.e., 3-min step, grip strength, sit-up, and sit and reach) and two body c
246 e to >=3 of the following 5 components: weak grip strength, slowed walking speed, poor appetite, phys
247  or more of the following 5 components: weak grip strength, slowed walking speed, poor appetite, phys
248 ss index (Spearman r=0.28, P<0.0001), weaker grip strength (Spearman r=-0.34, P<0.01), and slower wal
249 Ab levels were significantly correlated with grip strength (Spearman r=-0.57, P<0.005), walking speed
250 ures of physical capability at age 53 years: grip strength, standing balance, and chair-rise time.
251 , and occupational category using the lowest grip strength tertile as the referent.
252 2 times greater in the lowest vs the highest grip strength tertile.
253 clined plane and the pups were weaker on the grip strength test.
254                 All animals underwent weekly grip strength testing and were sacrificed 14 weeks follo
255 ced skeletal muscle function, as measured by grip strength tests 4 weeks after injection.
256  in mdx mice as demonstrated through in vivo grip strength tests and in vitro contraction measurement
257 ysfunction as determined by both rotorod and grip strength tests, as well as enhanced loss of motor n
258 .03), appendicular skeletal muscle mass, and grip strength than did controls, but these differences w
259 rthermore, mdx3cv mice had stronger forelimb grip strength than mdx4cv mice.
260 d fatigue and more significant reductions in grip strength than single alpha-syn-/- mutant and wild-t
261 ted more strongly with exercise capacity and grip strength than with lung function.
262 glycated hemoglobin, smoking, education, and grip strength, the opposite sex role of periodontitis an
263 for the functional measures of walk time and grip strength: the treatment groups improved more than t
264          Four physical function tests (i.e., grip strength, Timed Up and Go (TUG), 2-minute step test
265 ms and four measures of physical capability: grip strength, timed walk or get up and go, chair rises
266 5 and 0.025, respectively) but not with hand-grip strength, triceps skin-fold thickness (TSFT), or mi
267  coordination with the finger-nose test, and grip strength using the Jamar dynamometer.
268         Patients were clinically assessed on grip strength, vibration perception thresholds and postu
269 nd changes in the rate of decline of leg and grip strength, vital capacity, ALS Functional Rating Sca
270 9 (95% CI, 1.14-2.81) in the middle third of grip strength vs those in the highest third.
271 n; joint tenderness, swelling, or deformity; grip strength; walking velocity; and timed button test.
272 urrent work status; vital status at 6 years; grip strength; walking velocity; the timed-button test;
273                                              Grip strength was assessed using Smedley spring-type han
274                       In men, higher maximal grip strength was associated with an increased risk of O
275                                Baseline mean grip strength was associated with baseline lower bodyfat
276                                     Stronger grip strength was associated with better performance on
277                       Every 5-kg decrease in grip strength was associated with worse survival (adjust
278    A significant HRT-by-race interaction for grip strength was found; African-American HRT users had
279   Among healthy 45- to 68-year-old men, hand grip strength was highly predictive of functional limita
280                       Additionally, forelimb grip strength was improved after 1D11 treatment at both
281                                              Grip strength was improved significantly for both hands
282                                              Grip strength was increased and improved exercise capaci
283                                              Grip strength was linked to resting-state connectivity i
284 e healthy at baseline and whose maximal hand grip strength was measured from 1965 through 1970.
285                                              Grip strength was measured in kilograms by dynamometer i
286                    A significant decrease in grip strength was observed, coupled to small, but statis
287                                We found that grip strength was repeatable and differed between the se
288                                              Grip strength was tested using a hand-held dynamometer.
289 ly joint group significantly associated with grip strength was the CMCs, and only OA in the MCP joint
290                                              Grip strength was used as a marker of sarcopenia.
291 ate the genetic determinants of variation in grip strength, we perform a large-scale genetic discover
292  physical activity, slow walking speed, poor grip strength, weight loss, and exhaustion) and disabili
293  following criteria: slow walking speed, low grip strength, weight loss, exhaustion, and low physical
294 ural and environmental risk factors and hand grip strength were assessed as factors interfering with
295 d motor coordination impairments and reduced grip strength were detected in En2 null mutants.
296 y higher proportion of individuals with weak grip strength were in the lowest tertile of CMI.
297                           Unadjusted LBM and grip strength were similar in 2 groups.
298 cle alone but to be insufficient to maintain grip strength, whereas delivery to both motor neurons an
299 erformance was assessed by walking speed and grip strength, while global functional limitation, acros
300 , 2.17) than in those with stable weight and grip strength, with the highest risk in those with both

 
Page Top